๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Toward the harmonization of immune monitoring in clinical trials: Quo vadis?

โœ Scribed by C. M. Britten; S. Janetzki; S. H. van der Burg; C. Gouttefangeas; A. Hoos

Publisher
Springer-Verlag
Year
2007
Tongue
English
Weight
185 KB
Volume
57
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

THE ROLE OF META-ANALYSIS IN MONITORING
THE ROLE OF META-ANALYSIS IN MONITORING CLINICAL TRIALS
โœ COLIN B. BEGG ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 665 KB

The randomized clinical trial is the gold standard methodology for evaluating treatment interventions. The randomized trial is a prospective experimental study, the embodiment of the scientific method applied to the clinic. Both organizational and ethical considerations encourage the use of formal c

META-ANALYSIS IN THE DESIGN AND MONITORI
META-ANALYSIS IN THE DESIGN AND MONITORING OF CLINICAL TRIALS
โœ REBECCA DERSIMONIAN ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 828 KB

Results from external studies often play an important role in many aspects of a clinical trial. Their incorporation into the decision making process of a trial, however, is rarely conducted in a formal manner. This conference will address what formal role, if any, meta-analytic summaries of external

THE ROLE OF EXTERNAL EVIDENCE IN DATA MO
THE ROLE OF EXTERNAL EVIDENCE IN DATA MONITORING OF A CLINICAL TRIAL
โœ STUART J. POCOCK ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 684 KB

Data monitoring of interim results from a randomized clinical trial should take into consideration evidence from other trials. This article presents both scientific and practical issues regarding the pros and cons of formally incorporating such external evidence into the decision making process for

A phase I clinical trial of immunotherap
A phase I clinical trial of immunotherapy with interferon-ฮณ gene-modified autologous melanoma cells : Monitoring the humoral immune response
โœ Zeinab Abdel-Wahab; Christina Weltz; Dina Hester; Nancy Pickett; Carol Vervaert; ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 208 KB

and then 18 million for the fifth and sixth injections. The humoral immune responses of the patients were assessed by enzyme-linked immunoadsorbent assay, radioimmunoassay, and radioimmunoprecipitation. ## RESULTS. Thirteen of the 20 patients completed the immunization protocol. Eight of these 13